A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout

PHASE3CompletedINTERVENTIONAL
Enrollment

451

Participants

Timeline

Start Date

December 21, 2021

Primary Completion Date

June 14, 2023

Study Completion Date

June 14, 2023

Conditions
Gout
Interventions
DRUG

Dotinurad

Dotinurad oral tablets.

DRUG

Febuxostat

Febuxostat oral tablets.

OTHER

Dotinurad Matched Placebo

Dotinurad matched placebo oral tablets.

OTHER

Febuxostat Matched Placebo

Febuxostat matched placebo oral tablets.

Trial Locations (30)

10050

The Affiliated Hospital of Inner Mongolia Medical University, Hohhot

14010

First Affiliated Hospital of Inner Mongolia technological University, Baotou

100029

Beijing Anzhen Hospital,Capital Medical University, Beijing

100034

Beijing Hospital, Beijing

Peking University First Hospital, Beijing

101100

Beijing Tongzhou District Luhe Hospital, Beijing, P.R.China, Beijing

116011

The First Affiliated Hospital of Dalian Medical University, Dalian

116021

Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian

116023

The Second Hospital of Dalian Medical University, Dalian

130021

Jilin Province People's Hospital, Changchun

The First Hospital of Jilin University, Changchun

133000

Yanbian University Hospital, Yanji

200050

Tong Ren Hospital Shanghai Jiaotong University School of Medicine, Shanghai

200052

Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai

200090

The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen

210011

Nanjing Medical University Affiliated 2nd Hospital, Nanjing

210300

The First People's Hospital of Changzhou, Changzhou

225000

Northern Jiangsu People's Hospital, Yangzhou

230001

Anhui Provincial Hospital, Hefei

266000

The Affiliated Hospital of Qingdao University, Qingdao

337055

Jiangxi Pingxiang People's Hospital, Pingxiang

410013

The Third Xiangya Hospital of Central South University, Changsha

430030

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan

510080

Guangzhou First People's Hospital, Guangzhou

510280

Zhujiang Hospital of Southern Medical University, Guangzhou

518020

Shenzhen People's Hospital, Shenzhen

528000

Foshan First People's Hospital, Foshan

570311

Hainan General Hospital, Haikou

650032

The First People's Hospital of Yunnan Province, Kunming

Unknown

Jieyang People's Hospital, Jieyang

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT05007392 - A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout | Biotech Hunter | Biotech Hunter